You are here

Kymriah

Novartis hit with FDA letter detailing 'significant' Kymriah manufacturing shortfalls

Fierce Pharma

Thu, 12/7/23 - 10:08 am

drug manufacturing

Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah

Yahoo/Zacks.com

Tue, 05/31/22 - 10:41 am

relapsed or refractory follicular lymphoma

New fault lines emerge in CAR-T therapy

EP Vantage

Tue, 08/24/21 - 10:43 am

Bristol Myers Squibb

Gilead Sciences

clinical trials

Novartis-backed Penn study proposes boosting CAR-T responses in CLL by waking up 'war weary' T cells

Fierce Biotech

Tue, 08/17/21 - 10:20 am

#ASCO21: Novartis gears up for CAR-T fight with Gilead in follicular lymphoma — and safety could define the battle

Endpoints

Thu, 06/3/21 - 10:51 am

follicular lymphoma

Gilead Sciences

Novartis exec says Kymriah's ready to square off with Bristol Myers' new CAR-T rival Breyanzi

Fierce Pharma

Sun, 03/7/21 - 01:29 pm

Bristol Myers Squibb

ASH: Novartis makes its Kymriah case in follicular lymphoma, but another Gilead showdown awaits

Fierce Pharma

Sat, 12/5/20 - 11:38 pm

follicular lymphoma

clinical trials

Novartis says CAR-T cancer therapy works in second lymphoma type

BioPharma Dive

Tue, 08/4/20 - 12:40 pm

follicular lymphoma

FDA hastens development of Novartis’ Kymriah in follicular lymphoma

Pharmaforum

Wed, 04/22/20 - 10:35 am

follicular lymphoma

regenerative medicine

Novartis sidesteps Europe travel ban to provide CAR-T drug Kymriah to patients

Fierce Pharma

Fri, 03/13/20 - 12:41 pm

Novartis still hasn't solved its lingering CAR-T manufacturing issues

Biopharma Dive

Wed, 12/11/19 - 09:59 pm

drug manufacturing

Novartis Kymriah demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting

Pharmaceutical Business Review

Tue, 12/10/19 - 10:06 am

Celgene posts pivotal CAR-T data ahead of FDA filing

Fierce Biotech

Thu, 11/7/19 - 10:28 am

Expensive Gilead, Novartis cancer therapies losing patients to experimental treatments

Yahoo/Reuters

Tue, 07/30/19 - 07:51 am

Novartis takes another step forward in global Kymriah rollout as Japan OKs the drug at $305K

Endpoints

Wed, 05/15/19 - 10:31 am

Medicare would cover CAR-T cell therapies under new CMS proposal

Marketwatch

Fri, 02/15/19 - 12:22 pm

Gilead Sciences

Oncology round-up: CAR-T conference raises hopes for solid tumour therapy

Pharmaforum

Fri, 02/1/19 - 10:44 pm

Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company

Fierce Pharma

Fri, 02/1/19 - 12:00 am

diffuse large B-cell lymphoma

Gilead Sciences

Massachusetts Initiative Looks at Payment Plans for Novartis' SMA Gene Therapy

BioSpace

Mon, 01/14/19 - 11:55 pm

Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises

Fierce Pharma

Tue, 01/8/19 - 12:38 am

Pages